-

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions.

“We’re delighted to welcome Jason to the healthcare investment banking team. He brings extensive experience advising executives and boards across the tools and diagnostics landscape, both in Europe and globally. His perspective and relationships will further strengthen our ability to deliver strategic advice to clients worldwide,” said Peter Day, global group head of healthcare investment banking at Piper Sandler.

"I’m excited to join the global healthcare investment banking team, given its deep sector expertise and broad engagement across the healthcare ecosystem. I look forward to working with my partners to provide global clients with unique market insights and access to the firm’s leading platform, building on its strong foundation in life science tools and diagnostics to help clients execute complex strategic and capital markets decisions with confidence," said Arnold.

Prior to joining Piper Sandler, Arnold was a partner and managing director at William Blair, where he spent 16 years in its healthcare investment banking group. He began his career at Ernst & Young. Arnold received a bachelor’s degree and a master’s degree from the University of Colorado, Boulder.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2026. Since 1895. Piper Sandler Companies. 350 North 5th Street Minneapolis, MN 55401-5711

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

More News From Piper Sandler Companies

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr...

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

MINNEAPOLIS--(BUSINESS WIRE)--The complete earnings release can be found on the firm's website at pipersandler.com/earnings...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising bioph...
Back to Newsroom